2011
DOI: 10.3103/s0027131411040031
|View full text |Cite
|
Sign up to set email alerts
|

Quantitative immunofluorescent estimation of estrogen receptor β expression in human solid tumors using flow cytometry

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0
1

Year Published

2014
2014
2021
2021

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 7 publications
0
2
0
1
Order By: Relevance
“…The methodological approach used in this study, which was developed earlier to evaluate the expression of the multidrug resistance marker Pgp and estrogen receptor β [8,9], is devoid of subjectivity and allows strictly quantitative analysis of 5-10 thousand cells from a single cell suspension obtained from a suffi ciently large tumor specimen (up to 2 and even more cm in diameter). The vital importance of an integrated assessment of the level of expression of markers throughout the tumor site for accurate molecular diagnostics was convincingly demonstrated in a recent paper [11].…”
Section: Immunofluorescent Assay Of Ercc1 and Estimation Of Clinical mentioning
confidence: 99%
See 1 more Smart Citation
“…The methodological approach used in this study, which was developed earlier to evaluate the expression of the multidrug resistance marker Pgp and estrogen receptor β [8,9], is devoid of subjectivity and allows strictly quantitative analysis of 5-10 thousand cells from a single cell suspension obtained from a suffi ciently large tumor specimen (up to 2 and even more cm in diameter). The vital importance of an integrated assessment of the level of expression of markers throughout the tumor site for accurate molecular diagnostics was convincingly demonstrated in a recent paper [11].…”
Section: Immunofluorescent Assay Of Ercc1 and Estimation Of Clinical mentioning
confidence: 99%
“…In this study, the parameters of ERCC1 expression in ovarian cancer tissue were estimated by immunoflu orescent analysis with the use of flow cytometry, which has been adapted for the study of tumor markers in solid tissues, is devoid of subjectivity, and allows a strictly quantitative analysis of 5-10 thousand cells from tumor specimens up to 2 cm in diameter and larger [8,9].…”
mentioning
confidence: 99%
“…Ранее мы адаптировали иммунофлуоресцентный метод, ассоциированный с проточной цитометрией, для изучения опухолевых маркёров в ткани сóлидных новообразований [4]. По сравнению с ИГХ-исследованием метод обладает рядом преимуществ: мягкая преаналитическая подготовка, строго количественная оценка результатов, нивелирование молекулярной гетерогенности опухоли за счет исследования маркёра в большом объеме опухолевого образца [2].…”
Section: Introductionunclassified